Combining the inhibition of the Ras-MAPK pathway and the activation of the cAMP-PKA pathway as a therapeutic strategy for cutaneous neurofibromas

syn51658171

Created By NF Service nf-osi-service

grantDOI: https://doi.org/10.54464/pc.gr.160968
studyName: Combining the inhibition of the Ras-MAPK pathway and the activation of the cAMP-PKA pathway as a therapeutic strategy for cutaneous neurofibromas
dataStatus: Data Pending
initiative: Biology and Therapeutic Development for Cutaneous Neurofibromas
studyLeads: Eduard Serra
studyStatus: Active
diseaseFocus: Neurofibromatosis type 1
institutions: Germans Trias i Pujols Research Institute (IGTP)
fundingAgency: NTAP
relatedStudies: syn4939872 syn11374333 syn51356860 syn11374354
studyFileviewId: syn51658222
syn51658172
syn51658173
syn51658222
syn51658174

Combining the inhibition of the Ras-MAPK pathway and the activation of the cAMP-PKA pathway as a therapeutic strategy for cutaneous neurofibromas page is loading…